We are live on
!
Find out more
BTW
Boston Trust Walden Portfolio holdings
AUM
$12.2B
1-Year Est. Return
12.45%
This Fund
S&P 500
This Quarter
Est. Return
-5.84%
1 Year Est. Return
+12.45%
3 Year Est. Return
+44.66%
5 Year Est. Return
+68.67%
10 Year Est. Return
+295.88%
AUM
$5.99B
AUM Growth
-$571M
(-8.7%)
Cap. Flow
-$107M
Cap. Flow
% of AUM
-1.78%
Top 10 Holdings %
Top 10 Hldgs %
12.64%
Holding
363
New
17
Increased
100
Reduced
214
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACH
Accendra Health
ACH
|
+$32.5M |
| 2 |
Chemed
CHE
|
+$26.3M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$21.6M |
| 4 |
Oceaneering
OII
|
+$14.8M |
| 5 |
EV
Eaton Vance Corp.
EV
|
+$14.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
|
+$39.6M |
| 2 |
THOR
THORATEC CORPORATION
THOR
|
+$27.6M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$26M |
| 4 |
IPCM
IPC HEALTHCARE INC COM DTD
IPCM
|
+$24M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.98% |
| 2 | Technology | 15.56% |
| 3 | Healthcare | 15.35% |
| 4 | Industrials | 12.45% |
| 5 | Consumer Discretionary | 11.16% |
Similar funds
GLA
PIF
II
SMDAM
JIC
MG
BS
LC
Boston Trust Walden's Q3 2015 Portfolio in Review
As of Q3 2015, Boston Trust Walden held 363 positions worth $5.99B, down 8.7% from $6.56B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Boston Trust Walden's Q3 2015 filing shows 17 new, 100 increased, 214 reduced and 10 closed positions. Its largest new stake was Accendra Health: 954,271 shares worth $30.5M. The largest sale was BIO-REFERENCE LABS INC-NEW-, an estimated $39.6M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.
- Boston Trust Walden's largest Q3 2015 buy was Accendra Health: 954,271 shares worth $30.5M.
- Boston Trust Walden added most to Oceaneering in Q3 2015, an estimated $14.8M increase.
- Boston Trust Walden's biggest Q3 2015 reduction was Alphabet (Google) Class C, cutting an estimated $19.1M.
- Boston Trust Walden fully exited BIO-REFERENCE LABS INC-NEW- in Q3 2015, selling an estimated $39.6M.
- Boston Trust Walden's ten largest holdings make up 13% of its $5.99B portfolio in Q3 2015.
- Boston Trust Walden opened 17 new positions and closed 10 in Q3 2015.
- Boston Trust Walden's portfolio value fell 8.7% quarter-over-quarter to $5.99B.
Based on Boston Trust Walden's 13F filing for Q3 2015, filed 29 Oct 2015.